An N-acyl-D-galactosylsphingosine in which the anomeric configuration of the galactosyl residue is beta; sphingosine substituted at the O-1 position by a beta-D-galactosyl group and at the N-2 position by an acyl group.
ChEBI ID: 18390
| Member | Definition | Role |
|---|---|---|
| i(3)so3-galactosylceramide | A D-galactosyl-N-acylsphingosine having a sulfo group at the 3-position on the galactose ring and tetracosanoyl as the N-acyl group. | 1-(3-O-sulfo-beta-D-galactosyl)-N-tetracosanoylsphingosine |
| n-palmitoylgalactosylsphingosine | A D-galactosyl-N-acylsphingosine in which the ceramide N-acyl group is specified as hexadecanoyl. | N-(hexadecanoyl)-beta-D-galactosylsphingosine |
| phrenosin | A D-galactosyl-N-acylsphingosine in which the ceramide N-acyl group is specified as (R)-2-hydroxylignoceroyl. | 1-(beta-D-galactosyl)-N-[(2R)-2-hydroxylignoceroyl]sphingosine |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 650 (42.79) | 18.7374 |
| 1990's | 324 (21.33) | 18.2507 |
| 2000's | 280 (18.43) | 29.6817 |
| 2010's | 205 (13.50) | 24.3611 |
| 2020's | 60 (3.95) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 5 (0.32%) | 5.53% |
| Reviews | 100 (6.35%) | 6.00% |
| Case Studies | 71 (4.51%) | 4.05% |
| Observational | 1 (0.06%) | 0.25% |
| Other | 1,397 (88.75%) | 84.16% |